TELA Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	50.85	52.67	46.73	42.02	43.93
Cash & Short-Term Investments	50.85	52.67	46.73	42.02	43.93
Cash Growth	-3.46%	12.71%	11.21%	-4.35%	-40.95%
Accounts Receivable	10.35	10.1	9.74	6.62	4.23
Inventory	11.02	12.78	13.16	11.79	7.66
Other Current Assets	3.37	2.52	2.1	2.02	3.23
Total Current Assets	75.58	78.07	71.73	62.45	59.06
Net Property, Plant & Equipment	3.73	4.08	3.94	2.91	1.19
Other Intangible Assets	1.36	1.74	2.12	2.5	2.3
Other Long-Term Assets	0.75	2.68	0.27	-	-
Total Assets	81.42	86.57	78.05	67.86	62.54
Accounts Payable	2.31	2.15	1.67	1.53	2.41
Accrued Expenses	15.67	13.45	15.3	10.87	8.16
Total Current Liabilities	17.98	15.6	16.97	12.4	10.58
Long-Term Debt	55.65	41.12	40.52	39.92	31.49
Other Long-Term Liabilities	1.48	1.39	1.69	1.23	0.38
Total Long-Term Liabilities	57.13	42.51	42.2	41.15	31.87
Total Liabilities	75.11	58.11	59.17	53.55	42.45
Common Stock	0.04	0.04	0.02	0.02	0.02
Additional Paid-in Capital	403.74	387.06	339.66	288.36	250.06
Accumulated Other Comprehensive Income	0.09	0.09	0.09	0.15	-0.05
Retained Earnings	-397.56	-358.73	-320.89	-274.23	-229.93
Shareholders' Equity	6.31	28.46	18.88	14.31	20.1
Total Liabilities & Equity	81.42	86.57	78.05	67.86	62.54
Total Debt	55.65	41.12	40.52	39.92	31.49
Net Cash (Debt)	-4.81	11.55	6.21	2.1	12.44
Net Cash Growth	-	85.81%	195.48%	-83.09%	-71.45%
Net Cash Per Share	-0.10	0.41	0.27	0.13	0.86
Book Value	6.31	28.46	18.88	14.31	20.1
Book Value Per Share	0.13	1.00	0.83	0.88	1.39
Tangible Book Value	4.95	26.72	16.76	11.81	17.8
Tangible Book Value Per Share	0.11	0.94	0.73	0.73	1.23

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q